Our webinars allow users to learn from experts and earn continuing education credits on industry topics, progress in research, services available, and more.
Binding Site is committed to improving patient lives worldwide through education, collaboration, and innovation. We do this by providing automated special protein instruments and a wide range of high quality assays, with over 20 new assays FDA cleared in 2013 and 2014. Binding Sites SPAPLUS special protein analyzer is the newest, most efficient, cost-effective, and reliable instrument solution available for special protein testing. With a comprehensive menu of over 30 assays, the SPAPLUS is the perfect complement for todays lab. The Freelite assays, developed and provided exclusively by Binding Site, are considered standard-of-care for the diagnosis of Myeloma and other monoclonal gammopathies. Binding Sites Hevylite assays are now available in the U.S. Hevylite is a novel test for measurement of Myeloma serum proteins. Hevylite test results are used together with Freelite in the management of Myeloma patients. Binding Site is also the market leader for IgG and IgA immunoglobulin subclass reagents. In addition to our in vitro diagnostic portfolio, we provide a comprehensive product offering of antibodies, antigens, clinical specimens, collaborative immunoassay reagents, disease state sera, substrates, and contact manufacturing services for IVD manufacturers and suppliers. The Freelite assays, developed and provided exclusively by Binding Site, are considered standard-of-care for the diagnosis of Myeloma and other monoclonal gammopathies and suppliers.